Tag

Glp 1 Medications

All articles tagged with #glp 1 medications

Rapid GLP-1 Weight Loss May Leave Your Feet Uncomfortably Loose
health3 days ago

Rapid GLP-1 Weight Loss May Leave Your Feet Uncomfortably Loose

Some GLP-1 weight‑loss drugs can trigger feet that look bonier, feel painful, or no longer fit shoes after rapid weight loss. Doctors say this is usually due to thinning fat pads rather than a common drug side effect. Measures to prevent it include re-measuring feet, choosing the right shoe size, adding cushioning, and aiming for slower weight loss through adequate protein and resistance training; dose adjustments may help some patients.

Ozempic weight-loss outcomes vary sharply: a clinician explains why
health1 month ago

Ozempic weight-loss outcomes vary sharply: a clinician explains why

Some people on Ozempic lose more than 20% of body weight, while others lose little or nothing. Dr. Puopolo explains the big factors: the strongest predictor is early weight loss in the first three months; gender, diabetes status, and emotional eating also influence outcomes. Genetic variants can blunt drug response but have small effects, and baseline GLP-1 levels are not predictive. The gut microbiome may matter, and weight loss can include lean-mass loss, making protein and resistance training important. The Wegovy pill can be as effective as the shot if taken correctly. These drugs also affect brain reward and offer cardiovascular benefits beyond weight loss; stopping them often leads to weight regain, so personalize therapy and monitor response for at least three months rather than rely on a genetic test that is still years away.

GLP-1 Weight-Loss Drugs Linked to Lower Cancer Risk and Mortality in New Studies
health1 month ago

GLP-1 Weight-Loss Drugs Linked to Lower Cancer Risk and Mortality in New Studies

At ASCO's annual meeting, several studies suggest GLP-1 weight-loss drugs may reduce cancer risk and improve outcomes: in 110,000 women, a 30% lower incidence of breast cancer; in 27,000 breast cancer patients, a 30% lower risk of death when added to standard treatment; and in 12,000 patients with multiple cancers, a 38–50% lower likelihood of progressing to stage IV. The findings are observational and not yet definitive; more research is needed to determine whether benefits come from weight loss or direct anti-cancer effects, though anti-inflammatory and immune-modulatory mechanisms are plausible.

ACE Chief Urges Older GLP-1 Users to Protect Muscle and Mobility
weight-loss1 month ago

ACE Chief Urges Older GLP-1 Users to Protect Muscle and Mobility

ACE CEO Cedric X. Bryant says older adults using GLP-1 weight-loss meds should prioritize preserving strength, physical function and lean mass through regular resistance training (2-3 days/week; six-to-ten exercises; 1-3 sets; 8-15 reps) and adequate protein (roughly 1.2-1.6 g/kg/day), with targets tailored by age and health; programming should be individualized and safety-conscious, especially for those in their 70s and beyond.

Six essential moves to protect muscle and bone on GLP-1 weight-loss meds
health2 months ago

Six essential moves to protect muscle and bone on GLP-1 weight-loss meds

Glp-1 weight-loss meds can raise the risk of muscle and bone loss, so experts recommend a focused six-move home routine to preserve strength: goblet squat to chair, dumbbell Romanian deadlift, push-ups from the knees, seated resistance-band row, suitcase carry, and Pallof press. Perform 2–3 sets of roughly 6–12 reps for most moves (suitcase carry is about 1 minute per side). The workout can fit into a 50–60 minute weekly strength plan and should be undertaken with guidance from a physical therapist if starting fresh to ensure safe, effective practice.

GLP-1 Weight-Loss Drugs: Do You Need Supplements?
health4 months ago

GLP-1 Weight-Loss Drugs: Do You Need Supplements?

GLP-1 weight-loss injections can aid short-term weight loss but may raise nutrient-deficiency risks. Most evidence linking GLP-1 use to deficiencies is observational, and there’s no proof the meds directly cause deficiencies. Address nutritional needs with a varied diet and standard vitamin/mineral supplements if needed, rather than pricey “GLP-1” products. Guidance should be personalised and involve a healthcare professional; supplements are most beneficial only when a deficiency is identified or diet cannot meet needs.

Indiana Girl’s GLP-1 Mix-Up Leads to Hospitalization and a Call for Safer Medication Storage
health5 months ago

Indiana Girl’s GLP-1 Mix-Up Leads to Hospitalization and a Call for Safer Medication Storage

A 7-year-old Indiana girl injected about 60% of her mother’s GLP-1 diabetes medicine after misinterpreting it as stomach medicine, resulting in dehydration, vomiting, and a hospital stay. Doctors feared kidney failure, but she recovered after hospital treatment. Her mother now keeps the medication locked away to prevent a repeat incident, highlighting the importance of proper storage and supervision of prescription drugs for children.

7-year-old’s GLP-1 overdose spotlights rising safety concerns with popular meds
health5 months ago

7-year-old’s GLP-1 overdose spotlights rising safety concerns with popular meds

With GLP-1 prescriptions surging for diabetes and weight loss, a 7-year-old's self-injection and hospitalization spotlight a nationwide rise in GLP-1–related poison-center calls, driven mainly by accidental dosing; experts warn of dehydration, renal risk, and even pancreatitis, urging careful dosing, secure storage, and reputable sourcing to prevent misuse and counterfeit drugs.

Trini Doctors Return Home to Offer Stigma-Free Obesity Care
health5 months ago

Trini Doctors Return Home to Offer Stigma-Free Obesity Care

Trinidad-born doctors Dr. Robert Jupiter and Dr. Karen Moses return to Trinidad and Tobago to launch Stellar Medical, a stigma-free clinic focused on obesity and metabolic health. They emphasize treating obesity as a chronic, biology-driven disease, discuss GLP-1/GIP meds like Wegovy, Ozempic, Zepbound and Mounjaro, but prioritize nutrition, movement, hydration, sleep, and mental wellbeing, and will collaborate with therapists when needed.

Oprah Winfrey Reframes Weight Loss with Science and Self-Compassion
health6 months ago

Oprah Winfrey Reframes Weight Loss with Science and Self-Compassion

Oprah Winfrey reflects on decades of weight struggles, describing a biologically driven “enough point” and a shift from self-blame to a science-informed approach outlined in her book Enough with Dr. Ania Jastreboff. After resisting weight-loss medications for years due to shame, she started GLP-1–type drugs about two years ago, paired with daily hiking and resistance training, and now weighs about 155 pounds—the marathon weight—and says she feels healthier and stronger at 71 than at 40. Medical experts emphasize obesity as a treatable disease, not a personal fault, and Oprah’s openness aims to reduce stigma and encourage sustainable, health-focused strategies.

California halts weight-loss drug coverage despite TrumpRx price reductions
health6 months ago

California halts weight-loss drug coverage despite TrumpRx price reductions

California will cease Medicaid coverage for weight-loss drugs like Wegovy and Zepbound starting January 1, citing high costs and budget constraints, despite their effectiveness and popularity. The state recommends diet and exercise as alternatives, though experts say this may be unrealistic for many patients. Other states are also restricting coverage due to financial pressures, even as negotiated price reductions aim to lower drug costs. The move could impact thousands of low-income Californians relying on these medications for weight management and related health conditions.

Trump announces deals to cut obesity drug prices and expand Medicare coverage
healthcare8 months ago

Trump announces deals to cut obesity drug prices and expand Medicare coverage

The Trump administration announced deals with Eli Lilly and Novo Nordisk to lower the prices of blockbuster obesity drugs, making them as affordable as $149 for oral forms and reducing Medicare copays to expand access, with prices set to take effect in mid-2026, as part of efforts to lower drug costs and broaden treatment options for obesity and related conditions.